Sign In
Buy GLMD
$0.691
-0.0361 (-4.96%)
At Close: Jun 02, 2026
3 Healthcare Stocks Under $5 With Triple-Digit Upside Potential
07:30pm, Tuesday, 14'th Jul 2020
On Wall Street, some things never change. Public health crisis or not, the fact of the matter remains that healthcare stocks are the epitome of risk/reward plays. Why? It comes down to the nature of t
Here is What Hedge Funds Think About Galmed Pharmaceuticals Ltd (GLMD)
11:55am, Monday, 06'th Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Inventiva SA Starts U.S. IPO Rollout
03:52pm, Friday, 26'th Jun 2020
Inventiva SA has filed to raise $90 million in a U.S. IPO. The firm is advancing a pipeline of treatment candidates for NASH, MPS and other diseases. IVA is pre
How Galmed (GLMD) Stock Stands Out in a Strong Industry
12:34pm, Wednesday, 10'th Jun 2020
Galmed (GLMD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
B. Riley FBR Downgrades Galmed Pharmaceuticals to Neutral, Lowers Price Target of $8
10:03am, Friday, 22'nd May 2020Raymond James Maintains Outperform on Galmed Pharmaceuticals, Lowers Price Target to $20
12:30pm, Friday, 15'th May 2020Edited Transcript of GLMD earnings conference call or presentation 14-May-20 12:30pm GMT
07:29am, Friday, 15'th May 2020
Q1 2020 Galmed Pharmaceuticals Ltd Earnings Call
After Drug Failure, Genfit's Cupboard Is Nearly Bare
09:31pm, Thursday, 14'th May 2020
Company’s high hopes for NASH drug stymied, providing opening for Intercept Pharma treatment Continue reading...
Galmed Pharmaceuticals Q1 EPS $(0.290) Beats $(0.370) Estimate
11:04am, Thursday, 14'th May 2020Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
11:00am, Thursday, 14'th May 2020
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an oral
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
